. 2018 May 18;9(38):25148–25165. doi: 10.18632/oncotarget.25358

Table 1. Number of differentially expressed genes for different comparisons.

Group 1	Group 2	Total genes	Higher genes	Lower genes
Cisplatin ALDH^highCD44^high	Control ALDH^highCD44^high	231	115	116
Control ALDH^highCD44^high	Control ALDH^lowCD44^low	363	81	282
Cisplatin ALDH^highCD44^high	Cisplatin ALDH^lowCD44^low	605	104	501
Cisplatin ALDH^lowCD44^low	Control ALDH^lowCD44^low	1036	582	454

For each comparison, the total number of genes with an FDR adjusted p-value < 0.05, the number of genes higher in group 1, and the number of genes lower in group 1. Only genes with HUGO gene symbol are consider in this analysis.